Prolymphocytic leukemia of T-cell type, in relapse is a rare and aggressive hematological malignancy characterized by the proliferation of prolymphocytes. This condition is clinically significant due to its poor prognosis and the need for precise diagnosis and treatment. The ICD-10 Code C91.62 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this complex disease.
ICD-10 Code C91.62 represents Prolymphocytic leukemia of T-cell type, in relapse, a condition marked by the re-emergence of T-cell prolymphocytes after a period of remission. This code is essential for clinical documentation and billing, as it indicates the specific type of leukemia and its relapse status, guiding treatment decisions and ensuring appropriate resource allocation.
Prolymphocytic leukemia of T-cell type, in relapse, is caused by the uncontrolled proliferation of T-cell prolymphocytes, leading to significant hematological abnormalities. The condition can progress rapidly, necessitating immediate medical intervention to manage symptoms and prevent complications.
ICD-10 Code C91.62 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive patient management and facilitating communication among healthcare providers.
In SOAP notes, ICD-10 Code C91.62 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of prolymphocytic leukemia of T-cell type, in relapse. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prolymphocytic leukemia of T-cell type, in relapse, requires urgent medical attention and often hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C91.62 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 85025 | Complete blood count with differential. |
| 88305 | Pathology examination of bone marrow biopsy. |
| 96413 | Chemotherapy administration, intravenous. |
| 36415 | Collection of venous blood by venipuncture. |
Common Questions About Using ICD-10 Code C91.62 for Prolymphocytic leukemia of T-cell type, in relapse
What are the common symptoms of Prolymphocytic leukemia of T-cell type, in relapse?
Common symptoms include fatigue, weight loss, lymphadenopathy, and recurrent infections. Patients may also experience night sweats and fever, indicating disease progression.
How is Prolymphocytic leukemia of T-cell type, in relapse diagnosed?
Diagnosis is typically made through blood tests showing elevated prolymphocytes, bone marrow biopsy, and clinical evaluation of symptoms. Accurate coding with ICD-10 C91.62 is essential for proper documentation.
What treatment options are available for Prolymphocytic leukemia of T-cell type, in relapse?
Treatment often includes chemotherapy, supportive care, and potentially stem cell transplantation. Management of symptoms and prevention of infections are also critical components of care.
Why is accurate coding important for Prolymphocytic leukemia of T-cell type, in relapse?
Accurate coding with ICD-10 C91.62 ensures appropriate reimbursement, supports clinical decision-making, and facilitates effective communication among healthcare providers regarding patient care.
Clinical Notes
SOAP notes
DAP notes
AI medical notes